Fosfomycin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00828 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 49 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gonococcal urethritis | KG + DL |
| 2 | Ureaplasma urethritis | KG + DL |
| 3 | uterine inflammatory disease | KG + DL |
| 4 | xanthogranulomatous pyelonephritis | KG + DL |
| 5 | epiglottitis | KG + DL |
| 6 | urogenital tuberculosis | KG + DL |
| 7 | laryngitis | KG + DL |
| 8 | hyperamylasemia | KG + DL |
| 9 | polyclonal hyperviscosity syndrome | KG + DL |
| 10 | pyelitis | KG + DL |
| 11 | congenital analbuminemia | KG + DL |
| 12 | abdominal tuberculosis | KG + DL |
| 13 | blood group incompatibility | KG + DL |
| 14 | premalignant hematological system disease | KG + DL |
| 15 | IgG4-related mediastinitis | KG + DL |
| 16 | eosinophilic angiocentric fibrosis | KG + DL |
| 17 | IgG4-related mesenteritis | KG + DL |
| 18 | IgG4-related aortitis | KG + DL |
| 19 | IgG4-related pachymeningitis | KG + DL |
| 20 | monoclonal gammopathy | KG + DL |
| 21 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 22 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 23 | septicemic plague | KG + DL |
| 24 | congenital hematological disorder | KG + DL |
| 25 | IgG4-related hepatopathy | KG + DL |
| 26 | toxocariasis | KG + DL |
| 27 | post-infectious neuralgia | KG + DL |
| 28 | sequela of COVID-19 | KG + DL |
| 29 | hepatitis C induced liver cirrhosis | KG + DL |
| 30 | herpes zoster | KG + DL |
| 31 | toxascariasis | KG + DL |
| 32 | anisakiasis | KG + DL |
| 33 | Peptostreptococcus infectious disease | KG + DL |
| 34 | peritonitis | KG + DL |
| 35 | acute gonococcal cystitis | KG + DL |
| 36 | genital herpes | KG + DL |
| 37 | AIDS-related disorder | KG + DL |
| 38 | pneumonia | KG + DL |
| 39 | hematopoietic and lymphoid system neoplasm | KG + DL |
| 40 | malignant pleural mesothelioma | KG + DL |
| 41 | meningitis (disease) | KG + DL |
| 42 | type I complement component 8 deficiency | KG + DL |
| 43 | bubonic plague | KG + DL |
| 44 | malignant visceral pleura tumor | KG + DL |
| 45 | malignant epithelioid mesothelioma | KG + DL |
| 46 | sarcomatoid mesothelioma | KG + DL |
| 47 | arachnoiditis | KG + DL |
| 48 | rhinoscleroma | KG + DL |
| 49 | appendicitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.